Items where Author is "Villarroya, F"

Journal article

SHEEDFAR, F., VERMEER, M., PAZIENZA, V., VILLARROYA, J., RAPPA, F., CAPPELLO, F., MAZZOCCOLI, G., VILLARROYA, F., VAN DER MOLEN, H., HOFKER, M.H., KOONEN, D.P. and VINCIGUERRA, M., 2014. Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet. International Journal of Obesity, 39 (2), pp. 331-338. ISSN 1476-5497

PLANAVILA, A., VILLARROYA, F. and VINCIGUERRA, M., 2014. Nutrient signalling and cardiovascular aging. Heart and Metabolism (63), pp. 4-7.

PLANAVILA, A., REDONDO, I., HONDARES, E., VINCIGUERRA, M., MUNTS, C., IGLESIAS, R., GABRIELLI, L.A., SITGES, M., GIRALT, M., VAN BILSEN, M. and VILLARROYA, F., 2013. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nature Communications, 4. ISSN 2041-1723

PLANAVILA, A., DOMINGUEZ, E., NAVARRO, M., VINCIGUERRA, M., IGLESIAS, R., GIRALT, M., LOPE-PIEDRAFITA, S., RUBERTE, J. and VILLARROYA, F., 2012. Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. Journal of Molecular and Cellular Cardiology, 53 (4), pp. 521-531. ISSN 0022-2828

TONKIN, J., VILLARROYA, F., PURI, P.L. and VINCIGUERRA, M., 2012. SIRT1 signaling as potential modulator of skeletal muscle diseases. Current Opinion in Pharmacology, 12 (3), pp. 372-376. ISSN 1471-4892